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JAK/STATHuman RSV causes an annual epidemic of respiratory tract illness in infants and in elderly. Mechanisms by
which RSV antagonizes IFN-mediated antiviral responses include inhibition of type I IFN mRNA transcription
and blocking signal transduction of JAK/STAT family members. The suppressor of cytokines signaling (SOCS)
gene family utilizes a feedback loop to inhibit cytokine responses and block the activation of the JAK/STAT
signaling pathway. To evaluate the potential of SOCS molecules to subvert the innate immune response to
RSV infection, eight SOCS family genes were examined. RSV infection up-regulated SOCS1, SOCS3, and CIS
mRNA expression in HEp-2 cells. Suppression of SOCS1, SOCS3 and CIS by short interfering ribonucleic acid
(siRNA) inhibited viral replication. Furthermore, inhibition of SOCS1, SOCS3, or CIS activated type I IFN
signaling by inducing STAT1/2 phosphorylation. These results suggest that RSV infection escapes the innate
antiviral response by inducing SOCS1, SOCS3 or CIS expression in epithelial cells.
© 2009 Elsevier Inc. All rights reserved.IntroductionHuman respiratory syncytial virus (RSV), a major respiratory viral
pathogen, is an enveloped and negative-strand ribonucleic acid
(RNA) paramyxovirus that causes an annual epidemic of respiratory
tract illness in infants and in elderly and high-risk adults (Falsey,
2005; Sigurs et al., 2000). Severe RSV infection in early age causes
long-term morbidity and mortality by increasing the risk for
recurrent wheezing and asthma throughout childhood (Sigurs et
al., 2005; Stein et al., 1999). Respiratory epithelial cells, the principal
target for RSV infection, are the ﬁrst defense in the innate immune
response to this virus. In general, type I interferon(IFN), IFN-α/β, is
induced by viruses or double-stranded RNA in epithelia and activates
signal transduction pathways of IFN-stimulated genes (ISGs) (Decker
et al., 2002). To inhibit type I IFN expression, a number of viruses
have evolved mechanisms that interfere with either the induction of
these cytokines or the function of antiviral IFN-induced proteins
(Decker et al., 2002; Bode et al., 2003; Bossert and Conzelmann,
2002; Gotoh et al., 2001). The RSV nonstructural proteins, NS1 andchool of Medicine, Fukushima
81 24 548 6578.
ll rights reserved.NS2, have been demonstrated to block the antiviral effects of type I
IFN (Bossert and Conzelmann, 2002; Spann et al., 2004; Spann et al.,
2005; Valarcher et al., 2003). RSV infection interferes with type I IFN
signaling by speciﬁcally inhibiting signal transducer and activator of
transcription (STAT) 1/2 phosphorylation and by degrading STAT2,
thus providing a molecular mechanism for viral evasion of the host
innate immune response (Lo et al., 2005; Ramaswamy et al., 2004;
Zhang et al., 2005.
The suppressor of cytokine signaling (SOCS) family members are
important molecules that inhibit cytokine signaling (Naka et al., 1997;
Nicola et al., 1999; Starr et al., 1997). The SOCS gene family includes
eight members (SOCS1 to SOCS7 and CIS) which bind to tyrosine
kinases of Janus family kinase (JAK) elements, resulting in reduction
of JAK enzymatic activity and inhibition of tyrosine phosphorylation of
JAK/STAT factors (Hansen et al., 1999; Krebs and Hilton, 2000), (Krebs
and Hilton, 2001). According to recent studies, several virus accessory
proteins such as hepatitis C virus core (Bode et al., 2003) and herpes
simplex virus 1 UL41 (Yokota et al., 2005; Yokota et al., 2004) induced
SOCS3 expression. Also, expression of SOCS1 by cardiac myocytes
blocked enterovirus-induced activation of STAT-responsive genes
(Yasukawa et al., 2003).
We therefore hypothesized that RSV escapes from the host type I
IFN antiviral responses by modulating expression of the SOCS genes.
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2 cells infected with RSV. In addition, we deﬁned the effect of speciﬁc
SOCS family members on RSV infection by silencing their gene
expression by utilizing short interfering RNA (siRNA). Our results
demonstrate that RSV escaped type I IFN antiviral activity by up-
regulating SOCS1, SOCS3, and CIS, and that silencing the expression of
these genes by siRNA inhibited viral replication. These results suggest
that targeting SOCS gene family members could be an important
therapeutic target in preventing RSV-induced disease.
Results
RSV infection up-regulated epithelial cell mRNA expression of SOCS1,
SOCS3 and CIS
To examine SOCS expression in response to RSV infection, RT real-
time PCR was performed to screen mRNA expression of SOCS1–7 and
CIS in RSV-infected HEp-2 cells. At an moi of 3, SOCS1, SOCS3 and CIS
mRNA were rapidly induced following virus infection (Fig. 1). In the
early stage of RSV infection, SOCS1, SOCS3 and CIS expression
increased 9.6-fold, 13.8-fold and 7.3-fold compared to uninfected
cells (p b0.01), respectively. The peaks of expression were 1–2 h after
infection and decreased to the levels of uninfected cells by 24 h. RSV
infection nonsigniﬁcantly increased SOCS2 mRNA expression (2.6-
fold) compared to uninfected cells (Fig. 1). RSV infection did not
increase HEp-2 cell mRNA levels of SOCS4, SOCS5, SOCS6 or SOCS7
(data not shown). Incubationwith UV-inactivated virus did not induce
a signiﬁcant change in the HEp-2 cell mRNA expression of any of the
SOCS members, implying that viral gene expression is required for
increased SOCS expression. From these results, we conclude that RSV
replication is essential for the induction of SOCS1, SCOS3 and CIS, and
the increase of these SOCS members could regulate RSV replication in
vitro epithelial cell culture.
SiRNA against SOCS1, SOCS3 and CIS suppressed each SOCS expression
To determine the role of SOCS expression during RSV infection,
siRNA for SOCS1 (si-SOCS1), SOCS3 (si-SOCS3) and CIS (si-CIS) were
used to inhibit gene and protein expression of these molecules. At
ﬁrst, the siRNA inhibition efﬁcacy was determined by the suppres-
sion of GFP expression in HEp-2 cells by performing a co-
transfection experiment with a GFP-expression plasmid and its
siRNA(si-GFP) at a concentration of 20 nM. By microscopic
evaluation, the number of GFP expressing cells was decreased
greater than 80% compared to the control without siRNA, and this
silencing effect lasted at least 10 days (data not shown). Next, in
order to evaluate the efﬁcacy of si-SOCS1, si-SOCS3 and si-CIS (si-
SOCSs), HEp-2 cells were independently treated with si-SOCS at
20 nM for 24 h, then cells were stimulated with IFNα for 1 h . The
expression of each SOCS mRNA was suppressed over 90% by each
siRNA (Fig. 2A). In protein level, the induction of each SOCS protein
was decreased by each siRNA speciﬁcally at the time point of 6 h
after stimulation with IFNα in si-SOCS transfected HEp-2 cells (Fig.
2B). In induction with RSV infection, si-SOCSs were independently
transfected into HEp-2 cells 24 h prior to RSV infection to determine
the suppressive efﬁcacy of the siRNA against its respective SOCS
gene. At the time point that was 48 h after transfection and 24 h post
RSV infection, HEp-2 mRNA expression of SOCS1, SOCS3, and CIS was
suppressed in a dose dependent fashion by each of the siRNA. We
found that speciﬁc siRNA transfection at a concentration of 20 nM
reduced SOCS1, SOCS3 and CIS mRNAs by 31.8%, 29.4% and 25.8%
compared to that of no-siRNA control, respectively (Fig. 2C). While
treatment with si-GFP at any concentration had no effect on the
expression of SOCS1, SOCS3, and CIS, the treatment with the speciﬁc
si-SOCS decreased that gene's expression at 100 nM and 20 nM
compared to that of the si-GFP control (p b0.01).Suppression of SOCS1, SOCS3 and CIS inhibited RSV replication in
HEp-2 cells
After transfection of each si-SOCS or si-GFP to the HEp-2 cells,
cells were challenged with RSV at moi 1. The virus titers in the cell
culture supernatant were determined by a plaque-forming assay 24 h
post infection. The virus titers were decreased in a dose dependent
fashion for each si-SOCS (Fig. 3). The virus titer was suppressed over
80% by si-SOCS1, si-SOCS3, or si-CIS at a concentration of 20 nM
compared to that of no-siRNA control. While the treatment with si-
GFP at any concentration did not decrease viral replication, the
treatment with si-SOCS decreased viral replication at 100 nM and
20 nM compared to that with si-GFP control (p b0.05). These results
suggest that induction of SOCS1, SOCS3, and CIS by RSV infection is a
mechanism by which the virus increases viral titers.
Inhibition of SOCS1, SOCS3 and CIS activated IFN signal pathway
The SOCS gene family utilizes a feedback loop to inhibit cytokine
responses and block the activation of the JAK/STAT signaling pathway
(Krebs and Hilton, 2001). To determine the mechanism by which the
siRNAs for SOCS1, SOCS3, and CIS mediate reductions in viral titers of
RSV-infected HEp-2 cells, we ﬁrst examined the association between
the concentration of each si-SOCS and JAK/STAT activation. Real-time
PCR was performed to evaluate mRNA levels for 2′–5′OAS1 in HEp-2
cells 48 h after transfection. Poly I:C was used as a positive control for
an inducer of type I IFN signaling (Schaefer et al., 2005). Expression
of 2′–5′OAS1 increased in a dose dependent fashion in parallel with
the concentration of siRNA administered for SOCS1, SOCS3, and CIS
(Fig. 4A). However, si-GFP also induced the expression of 2′–5′OAS1
at a concentration of 100 nM, but the expression of 2′–5′OAS1 was
the same level as the control when the siRNA concentration was
decreased to 20 nM. These results suggest that inhibition of SOCS1,
SOCS3 and CIS promote expression of IFN-inducible genes and that a
high concentration of siRNA might activate JAK/STAT1 signaling by
the nature of being double-stranded RNA (Shen et al., 2004; Sledz
et al., 2003). The later experiments were performed with 20 nM at
the concentration of siRNA.
Next, we examined the effect of each si-SOCS on IFN-inducible
gene, 2′–5′OAS1, mRNA in RSV-infected cells (Fig. 4B). In RSV-infected
HEp-2 cells, si-SOCS1 (p b0.05) or si-SOCS3 (p b0.05) at a concentra-
tion of 20 nM each signiﬁcantly increased 2′–5′OAS1 mRNA expres-
sion, compared to si-GFP control. These results suggest that cells
treatedwith si-SOCS are released from the negative regulation of SOCS
on JAK/STAT1 signal transduction.
si-SOCS activated type I IFN-induced STAT1/2 phosphorylation
It has been reported that RSV infection not only speciﬁcally
inhibits type I IFN-induced phosphorylated STAT1 and STAT2 (p-
STAT), but also selectively inhibits STAT2 expression (Lo et al., 2005;
Ramaswamy et al., 2004; Zhang et al., 2005). To further assess the
role of si-SOCS in regulating JAK/STAT signaling, immunoblot
analysis was performed to check the expression of STAT1/2 and
their phosphorylated isoforms (Fig. 5). Since STAT phosphorylation is
an early response to type I IFN signaling, we examined the time
course of STAT phosphorylation in response to RSV infection. Poly I:C,
a strong type I IFN inducer as a consequence of binding to toll-like
receptor 3 (TLR3), was used as a positive control (Fig. 5A). There was
no effect of si-SOCS1 or si-SOCS3 beside si-CIS on the basal levels of
total STAT1 (tSTAT1) to si-GFP-treated cells. Also, there was no effect
of si-SOCS1, si-SOCS3, or si-CIS on the basal levels of total STAT2
(sSTAT2) compared to si-GFP-treated cells (Figs. 5B, C, D, E, F, H).
While total STAT2 of si-GFP treated cells was decreased at 4 h post
RSV infection (Figs. 5B, H), total STAT2 of si-SOCS3 treated cells was
increased (Figs. 5D, H). The cells treated with si-SOCS1, si-SOCS3, or
Fig. 1. RSV induced SOCS1, SOCS3 and CIS mRNA expression in the HEp-2 cells. HEp-2 cells were infected with puriﬁed RSV at moi 3 or treated with the same amount of UV-
inactivated RSV. Total RNA was extracted at the indicated times for RT real-time PCR. Panels A, B, C, D show the fold increase in mRNA levels of SOCS1, SOCS2, SOCS3 and CIS
expression, respectively, following RSV infection compared to the value at time 0 (uninfected cells). Data is expressed as the mean±SE of three independent experiments. ⁎p b0.01
versus time zero.
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compared to si-GFP treated cells (Figs. 5B, C, D, E, G, I). STAT1/2
phosphorylation was observed in all groups treated with si-SOCS at
the designated time points after RSV infection, while there was a
faint signal of STAT1/2 phosphorylation in the group treated with si-
GFP (Figs. 5B, G, I). RSV infection resulted in a further up-regulation
of pSTAT1 in si-SOCS3 treated cells (Fig. 5D), while RSV infection
resulted in suppression of pSTAT1 in si-CIS treated cells in a time
dependent fashion (Figs. 5E, G). Interestingly, si-SOCS1, si-SOCS3 and
si-CIS had no effect on RSV infection-induced STAT2 phosphorylation
(Figs. 5B, C, D, I) while poly I:C suppressed STAT2 phosphorylation
(Fig. 5A). These results indicate that inhibition of SOCS1, SOCS3 or CIS
induce both STAT1 and STAT2 phosphorylation; furthermore, si-
SOCS1, si-SOCS3, and si-CIS could inhibit RSV replication by STAT1/2
phosphorylation.
Discussion
A main focus of these studies was to understand how virus
subverts the IFN-inducible antiviral response (Decker et al., 2002;
Horvath, 2004). Some RNA and DNA viruses have been reported to
inhibit the innate immune response (Bode et al., 2003; Bossert and
Conzelmann, 2002; Zhang et al., 2005; Yokota et al., 2004). Previous
studies have elucidated some mechanisms of how paramyxoviridae
family, including RSV, could attenuate type I IFN-induced antiviral
activity (Gotoh et al., 2001). We have already reported that RSV
infection of macrophage-like U937 cells results in increased expres-
sion of SOCS1, SOCS3, and CIS mRNA, while phosphorylation of STAT1
and STAT2 was shown to be decreased (Zhao et al., 2007). In this work
we provide experimental evidence that RSV infection resulted in up-
regulation of SOCS1, SOCS3, and CIS in HEp-2 cell originated from
human epithelial cells. Furthermore, suppression of these SOCS genes
by using siRNA inhibited RSV replication in vitro.
Signaling by several cytokines which activate the JAK/STAT path-
way has been blocked by SOCS family proteins via a negative feedbackregulation mechanism (Hansen et al., 1999; Krebs and Hilton, 2000;
Narazaki et al., 1998). Virus-induced expression of the SOCS molecules
efﬁciently counteracts the cellular response which leads to IFN-
inducible antiviral gene expression (Bode et al., 2003; Brand et al.,
2005). For example, overexpression of the human hepatitis virus C core
protein results in induction of SOCS3 mRNA expression in human
hepatic cells and is associated inhibition of IFN-α-induced tyrosine
phosphorylation and activation (Bode et al., 2003; Kawaguchi et al.,
2004). Herpes simplex virus type 1 infection induces SOCS3 protein,
which is mainly responsible for the suppression of type I IFN signaling
and its products. Transfection of antisense oligonucleotides for SOCS3
suppressed HSV-1 replication in a human amnion cell line (Yokota
et al., 2004). Additionally, cardiac myocyte-speciﬁc transgenic expres-
sion of SOCS1 inhibited the expression of STAT-responsive genes as a
result of enterovirus infection and there was an associated increase in
viral replication (Yasukawa et al., 2003). Furthermore, SOCS1 inhibi-
tion using dominant-negative SOCS1 in the cardiac myocytes increased
resistance to the acute cardiac injury caused by enteroviral infection.
In our experiments, we screened all eight SOCS members
(SOCS1–7, and CIS), and found that RSV infection rapidly induced
SOCS1, SOCS3 and CIS mRNA expression. In the supernatant of RSV-
infected HEp-2 cells, INF-β was detected since 12 h post infection.
Maximal induction of INF-beta was at 24 h post infection (data not
shown). RNA expression of SOCS-1, SOCS-3, and CIS was induced in
the very early stage of infection within 1 h. Oshansky et al. (2009)
reported RSV surface proteins induce SOCS-1, and SOCS-3 in the very
early stage of infection via the Toll-Like Pathway (TLR) in fully-
differentiated primary normal human bronchial epithelial (NHBE)
cells within 15 min. There are some reports that SOCS proteins can
also be induced through TLR stimulation independent of type I IFN
(Baetz et al., 2004; Dalpke and Heeg, 2003; Dalpke et al., 2001;
Nakagawa et al., 2002). Furthermore, RIG-I, an intracellular receptor
that binds to dsRNA in the cytosol and can induce type I IFN
independent of TLR signaling (Yoneyama et al., 2004), may be
associated with signaling following RSV infection. These indicate
165K. Hashimoto et al. / Virology 391 (2009) 162–170that RSV infection affect SOCS negative regulation of the type I IFN
response, an attribute associated with cross-talk between the TLR and
JAK/STAT pathways. Our results also indicated SOCS expression in the
very early stage of infectionwas induced not by IFN, but by RSV surface
protein.
SOCS1 binds to JAKs to inhibit catalytic activity (Nicola et al., 1999;
Alexander et al., 1999). Others have found that overexpression of SOCS1
completely abolished mRNA expression of the IFN-α inducible antiviral
genes 2′–5′OAS1 and MxA (Brand et al., 2005; Vlotides et al., 2004).
SOCS3 inhibits JAK activation through its N-terminal domain associated
with an activated receptor (Nicholson et al., 2000). Expression of SOCS3
mainly inhibits 2′–5′OAS1 mRNA transcription (Vlotides et al., 2004).Fig. 2. The effect of si-SOCSs on SOCS1, SOCS3, and CIS gene and protein expression. (A) HE
20 nM. After 24 h, cells were stimulated with IFNα for 1 h , RNAwas then extracted and real-
using the delta/delta Ct method with expression of GAPDH. ⁎p b0.01 versus no-siRNA. (B) F
treatment. At 6 h following IFNα treatment, cell lysateswere harvested for western blotting a
(1:200 for SOCS1 and CIS, 1:100 for SOCS3, 1:10,000 for β-actin) and secondary antibodies (1
si-CIS(c), was transfected into HEp-2 cells to silence these SOCS family members, and siRNA
were seeded on 96-well plates and treated with siRNA at indicated doses for 24 h, followed b
the mRNA level of each SOCS family members. The black bar indicated the treatment with ea
GAPDH mRNA levels and shown as the percentage of that of no-siRNA (gray bar). ⁎p b0.01The CIS gene was induced by STAT5 in response to erythropoietin and
growth factor (Erickson-Miller et al., 2000; Wang and Jiang, 2005;
Yoshimura et al., 1995), but how it regulates IFN signal transduction is
still unclear. STAT1 is a main pathway of many interferon-stimulated
genes in response to IFNs (Sledz et al., 2003; Bromberg et al.,1996). IFN-
activated STAT2 contributes to IFN-inducible biological responses that
are independent of IFN-stimulated gene factor 3 (ISGF3) activity by
forming a heterodimer with STAT1 that will bind to chromatin and
determine transcriptional activation that contributes to IFN-inducible
biological responses (Brierley and Fish, 2005). Under the condition of
RSV infection, inhibition of SOCS1, SOCS3 or CIS by using each siRNA
independently promoted expression of STAT1/2 and their phosphory-p-2 cells were transfected independently with siRNA, si-SOCS1, si-SOCS3 and si-CIS at
time RT-PCR was performed to evaluate SOCS expression. The data was then normalized
or protein analysis, cells were treated with siRNA at 20 nM for 24 h, followed by IFNα
nalysis. After transferring blots, themembraneswere incubatedwith primary antibodies
:5000). (C) siRNA speciﬁc for SOCS1, SOCS3, or CIS mRNA; si-SOCS1(a), si-SOCS3(b), or
for GFP(si-GFP) was used as a control. To assess efﬁcacy of target gene inhibition, cells
y virus infection at moi 1. At 24 h after infection, Taqman PCR was performed to quantify
ch si-SOCS, the white bar indicated the treatment with si-GFP. Data were normalized to
versus si-GFP control at the same concentration.
Fig. 3. The inhibitory effect of various concentrations of siRNA on RSV-replication. si-
SOCSs were independently transfected into HEp-2 cells, and siRNA for si-GFP was used
as a control. HEP-2 cells were seeded on 96-well plates and treated with siRNA at
indicated doses for 24 h, followed by virus infection at moi 1. The virus titers that were
in supernatant were determined by a plaque-forming assay 24 h post infection. The
transfection with si-SOCS1, si-SOCS3, si-CIS, or si-GFP is indicated by a black bar, gray
bar, white bar, or a dotted line, respectively. ⁎p b0.01, and ⁎⁎p b0.05 versus si-GFP
control at the same concentration.
Fig. 4. Inhibition of SOCS1, SOCS3 and CIS induced the expression of IFN associated
genes. (A) Effect of si-SOCS on the expression of 2′–5′OAS1 gene was compared with si-
GFP in non-infected HEp-2 cells determined by real-time PCR. Poly I:C was used as a
positive control (see Materials and methods). The ﬁnal concentrations of poly I:C were
14 μg, 2.8 μg, 0.56 μg, 0.11 μg and 0.02 μg/100 μl/well. Data were normalized to GAPDH
mRNA level and shown as a percentage of poly I:C at the highest concentration (14 μg/
100 μl/well) of transfected cells (adjusted as 100%). The transfection with si-SOCS1, si-
SOCS3, si-CIS, si-GFP, or poly I:C is indicated by a black bar, gray bar, white bar, dotted
line, or a solid line, respectively. (B) The effect of si-SOCS on the expression of 2′–5′OAS1
gene was compared with si-GFP in RSV-infected HEp-2 cells. Cells were treated with
siRNA at a concentration of 20 nM for 24 h, followed by virus infection at moi 1. 24 h
post viral infection, 2′–5′OAS1 were assayed by real-time PCR. ⁎p b0.05 versus si-GFP
control.
166 K. Hashimoto et al. / Virology 391 (2009) 162–170lation, while RSV infection without si-SOCS treatment did not induce
sufﬁcient expression and phosphorylation of STAT1/2. These results
indicate that SOCS1, SOCS3, and CIS block the expression and
phosphorylation of STAT1/2, providing a possible mechanism for
virus evasion of the host cell antiviral response.
An important clinical aspect of RSV infection is the link between
severe RSV disease in childhood and the development of allergic
asthma later in life (Sigurs et al., 2000). There is evidence to suggest
that the ability to signal through STAT1 might be critically important
in protecting against RSV-induced Th2 immune responses and airway
disease. For instance, RSV infection in the absence of STAT1-dependent
IFN signaling in mice fundamentally changes the immune response to
RSV infection. In wild type (WT) mice on a BALB/c background, RSV
infection resulted in a predominant Th1 immune response with high
levels of IFN-γ in the lung. However, RSV infection in STAT1 knock-out
(KO) mice of the same genetic background resulted in a mixed Th1/
Th2 response with high levels of Interleukin-4, Interleukin-5, Inter-
leukin-13, and even higher levels of IFN-γ than seen in the WT mouse
(Durbin et al., 2002; Johnson et al., 2005). RSV infection increased
airway obstruction, airway hyperresponsiveness and airway epithelial
mucus production in STAT1 KO mice (Hashimoto et al., 2005), while
these features were not present in RSV-infected WT mice. Others have
also shown that inducing Type I IFN expression can prevent Th2
immune responses as a result of RSV infection. For instance,
administration of cytosine phosphate-guanine-oligodeoxynucleotides
(CpG-ODN) which bind TLR9 and induce production of IFN-α, β,
inhibit RSV-enhanced allergic sensitization in guinea pigs by increas-
ing lung IFN-γ/IL-5 ratios and signiﬁcantly reducing airway T-cells and
eosinophils (Tayyari et al., 2005). Therefore, increasing STAT1-
mediated signaling by inhibiting SOCS expression might be a
therapeutic target to prevent severe RSV bronchiolitis in infancy.
This possibility is supported by the ﬁnding that silencing SOCS1
enhances antigen presentation by dendritic cells and augments
cellular immunity with induction of IFN-γ secretion in CD8 T cells
(Shen et al., 2004). Therefore, treatment with siRNA against SOCS1
might be a relevant intervention in the context of post-bronchiolitis
allergic sensitization in children.
Taken together, we conclude that RSV evades the innate antiviral
response by inducing SOCS1, SOCS3 and CIS in infected epithelial cells.
We found that suppression of SOCS resulted in inhibition of virus
replication. Meanwhile, silencing of SOCS molecules possibly providesa new anti-virus strategy in the early stage of infection by activating
innate immunity to antiviral response.
Materials and methods
Cells and virus
HEp-2 cells were maintained in Eagle's minimal essential medium
supplementedwith glutamine, amphotericin, gentamicin, penicillin G,
and 10% fetal bovine serum (10%FBS-MEM). The RSV A2 strain was
originally provided by Dr. Robert Chanock at the National Institutes of
Health (Bethesda, MD). Master stocks and puriﬁed virus working
stocks of RSV were prepared as previously described (Graham et al.,
1988; Schwarze et al., 2000) and snap frozen until use. In order to
remove bioactive substances in the supernatant, ultra-centrifuged
puriﬁed RSVwas used in this study. Brieﬂy, cells and supernatant were
harvested, the cells were disrupted by ultrasonic manipulation, and
the suspensionwas clariﬁed by centrifugation (8000 ×g, 20 min). The
supernatant was layered over 30% sucrose in STEU buffer (sodium
chloride 0.1 M, Tris 0.01 M, ethylenediaminetetraacetic acid [EDTA]
0.001 M, and urea 1 M, all obtained from Sigma [St. Louis, MO]) and
centrifuged (100,000 ×g , 1 h, 10° C). The pellet was resuspended in
1.2 ml phosphate-buffered saline (PBS), aliquoted and frozen at 70 °C
(Schwarze et al., 2000). RSV stocks were titered by methylcellulose
plaque assay. Inactivated virus was prepared by exposing the viral
stock to 254-nm ultraviolet light for 15 min on ice. UV-inactivation
RSV was veriﬁed that inactivated virus could not make CPE in HEp-2
cell, and could not replicate determined by real-time quantitative PCR.
167K. Hashimoto et al. / Virology 391 (2009) 162–170Unless otherwise mentioned, virus infection was performed at a
multiplicity of infection (moi) 1.
Real-time polymerase chain reaction
Taqman PCR reagents for SOCS1–7 and CIS were purchased from
ABI (Applied Biosystems, Foster City, CA). To determine activation of
the pathway leading to the induction of the type I IFN, expression of
2′–5′ oligoadenylate synthetase 1 (2′–5′OAS1) was examined by
Interferon Response Watcher kit using the SYBR Green method
(Takara, Shiga, Japan). Total cell RNA was extracted by IsoGene
(NipponGene, Tokyo, Japan). One microgram of total RNA was used
for the reverse transcription (RT) reaction with Supercript III
(Invitrogen Life Technologies, Carlsbad, CA). Taqman PCR for
SOCS1–7 and CIS was performed according to the Taqman Master
Mix reagents kit protocol supplied by the manufacturer (Applied
Biosystems, Foster City, CA). Thermal Cycler conditions: the reactions
were incubated for 2 min at 50 °C followed by 10 min denaturation
at 95 °C; then the reactions were run for 40 cycles of denaturation
for 15 s at 95 °C and an extension for 1 min at 60 °C per cycle using
the ABI Prism® 7000 Sequence Detection System (Applied Biosys-
tems, Foster City, CA). The real-time polymerase chain reaction (PCR)
data was analyzed using the standard curve method or delta/delta Ct
method. For the standard curve method, at the begining, the
maximum expression of each SOCS gene in RSV-infected cell was
checked. Then, standard curves in each SOCS genes were made by
serial 5 times dilution with c-DNA for each SOCS gene. For RSV,
GAPDH, standard curves were made in the same way. Finally, data
were standardized by glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Applied Biosystems, Foster City, CA), and presented as a
relative value. For delta/delta Ct method, Ct value of GAPDH is used
for normalization of target gene expression.Fig. 5. si-SOCS activated STAT1/2 phosphorylation. Cells were treated with siRNA at a concent
a non-RSV-infected cell, just before infection. At 1, 2, and 4 h following RSV infection, cell lysa
were incubated with primary antibodies (1:500 for STAT1/2 and pSTAT1/2, 1:10,000 for β-ac
si-GFP (B) were used as positive and negative controls. The immunoblotting images from cel
are representative of three independent experiments. The data was analyzed by densit
phosphorylated STAT1 (pSTAT1) (G), total STAT2 (tSTAT2) (H), and phosphorylated STAT2
experiments. Histograms show the fold increases in densitometry of each protein compared t
b.l. in si-GFP. Comparison within the group: ⁎⁎p b0.05 versus b.l. in the same group.Induction of SOCS genes by IFNα
IFNα is a well known potent SOCS inducer. To induce SOCS gene or
protein, HEp-2 cells were stimulated by IFNα-2b (INTRON®, Schering-
Plough Co, Kenilworth, NJ) of 2000 IU/ml at the ﬁnal concentration.
Target siRNA design and transfection
We designed siRNA against to SOCS1, SOCS3, CIS and GFP (Green
Fluorescent Protein) mRNA using a program provided by RNAi Co.
(Tokyo, Japan, http://design.rnai.jp/sidirect/index.php) (Table 1).
This program can select highly effective and selective siRNA sequences
using novel guidelines that were established through an extensive
study of the relationship between siRNA sequences and RNA
interfering activity to avoid off-target gene silencing (Naito et al.,
2004). The siRNA against Green Fluorescent Proteins (GFP) was
selected as a negative control for silencing human genes. One day
prior to transfection, 1×105 or 1×104 of HEp-2 cells were seeded into
24-well or 96-well plates, respectively (Wu et al., 2004). Once cells
were 50% conﬂuent, siRNA was transfected into the HEp-2 cells. For
siRNA transfection, cationic lipid complexes were prepared according
to the instruction of Stealth™ RNAi-Lipofectamine™ 2000 (Invitrogen
Co., CA). For 24-well plate, siRNA and 0.8 μl of Lipofectamine2000
were incubated in 100 μl of Opti-MEM I Reduced Serum Medium
(Opti-MEM) (Gibco, Grand Island, N.Y.) at room temperature for
15 min, then added with 10% FBS-MEM without antibiotics resulting
in 500 μl at the ﬁnal volume. For 96-well plate, siRNA and 0.2 μl of
Lipofectamine 2000 were incubated in 25 μl of Opti-MEM at room
temperature for 15 min, then added with 10% FBS-MEM without
antibiotics resulting in 125 μl at the ﬁnal volume. The cells were
transfected with the siRNA/Lipofectamine2000 complex at a volume
of 400 μl/well for 24-well plates and 100 μl/well for 96-well plates.ration of 20 nM for 24 h, followed by virus infection at moi 1. The basal level (b.l.) meant
tes were harvested for western blotting analysis. After transferring blots, themembranes
tin) and secondary antibodies (1:10,000). Poly I:C (26 μg/ml in 12-well plates) (A) and
ls treated with si-SOCS1 (C), si-SOCS3 (D) and si-CIS (E) were shown. The results shown
ometer, then normalized to β-actin signal. The graph of total STAT1 (tSTAT1) (F),
(pSTAT2) (I) were shown. Data is expressed as the mean±SE of three independent
o b.l. of si-GFP that is taken as one. Basal level comparison among group: ⁎p b0.05 versus
Fig. 5 (continued).
168 K. Hashimoto et al. / Virology 391 (2009) 162–170The ﬁnal concentrations of siRNA used in the experiments were
100 nM, 20 nM, 4 nM, 0.8 nM, 0.16 nM, and 0 nM. The transfected cells
were incubated at 37 °C in a 5% CO2 incubator for 24 h until RSV
inoculation.Table 1
siRNA duplexes against human SOCS genes and GFP.
Oligo name Location siRNA
SOCS1 800–822 Sense strand
Antisense strand
SCOC3 1334–1356 Sense strand
Antisense strand
CIS 657–679 Sense strand
Antisense strand
GFP 509–531 Sense strand
Antisense strandTo determine the inhibition efﬁcacy of the siRNA, co-transfections
of pFB-hrGFP (Stratagene, La Jolla, CA) and siRNA for GFP (si-GFP)
were performed using Lipofectamine 2000 according to the manufac-
turer's protocol. Brieﬂy, 0.4 μg of pFB-hrGFP was co-transfected withNucleotide sequence (5′–3′) Genbank accession no.
CGCCGUGCACGCAGCAUUAAC NM_003745.1
UAAUGCUGCGUGCACGGCGGG
CCUGGUGGGACGAUAGCAACC NM_003955.3
UUGCUAUCGUCCCACCAGGAC
CCAAUGUACGCAUUGAGUAUG NM_013324.4
UACUCAAUGCGUACAUUGGUG
CUGAACAGCGGCAAGUUCUAC AY613996
AGAACUUGCCGCUGUUCAGGC
169K. Hashimoto et al. / Virology 391 (2009) 162–17020 nM si-GFP to the HEp-2 cells. Forty-eight hours after transfection,
the cells were observed under ﬂuorescence microscopy (Zeiss,
Oberkochen, Germany) and the transfection efﬁciency was determined.
Western blot analyses
Cells were lysed in a buffer [20 mM Tris–HCl (pH 7.4), 0.5% sodium
deoxycholate, 10% glycerol, 150 mM NaCl, 2 mM Ethylene Diamine
Tetra-Acetic acid (EDTA), 50 mM β-glycerophosphate, 2 mM Na3VO4,
10 mM NaF, 1 mM Dithiothreitol (DTT), 1 mM Phenylmethylsulfonyl
Fluoride (PMSF), and 0.1% protease inhibitor cocktail (Roche, Penz-
berg, Germany)] and incubated for 30 min on ice, then centrifuged at
15,000 rpm for 15 min. The protein concentrations of the supernatant
were determined with DC protein assay kit (Bio-Rad, Hercules, CA).
Ten micrograms of protein or 20 μg of protein were applied into each
well to analyze STAT protein or SOCS protein, respectively. The sample
was electrophoresed on a 4.75% stacking/10% separating sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel
and transferred to a polyvinylidine diﬂuoride (PVDF) membrane
(Immobilone; Millipore, Schwalbach, Germany). The membranes
were blocked with 5% nonfat milk powder in 50 mM Tris–HCl (pH
7.6), 0.15 M NaCl, and 0.1% Tween 20 (TBS-T) for 1 h, then incubated
with the following primary monoclonal (mAb) or polyclonal (pAb)
antibodies: goat anti-human SOCS1 pAb (sc-7005, Santa Cruze, CA),
rabbit anti-human SOCS3 pAb (C204, IBL, Takasaki Japan), goat anti-
human CIS pAb (sc-1529, Santa Cruz, CA), mouse anti-human STAT1
and STAT2-pAb (Santa Cruz, CA), rabbit anti-human p-STAT1 and p-
STAT2-pAb (Santa Cruz, CA), and mouse anti-β-actin mAb (Sigma,
Saint Louis, MO) in dilution buffer with agitation at 4 °C overnight.
After washing, the membranes were incubated with a horseradish
peroxidase-conjugated secondary antibody for 1 h. Protein bands
were visualized using ECL plus Western detection reagents (Amer-
sham-Pharmacia Biotech, Buchinghamshire, England), and imaged
with Image Reader LAS-3000 (Fuji Film Tokyo, Japan), then the
density of each band was measured using the program, NIH image.
2′–5′ OAS-1 gene expression analysis
The HEp-2 cells were seeded into 96-well plates at a density of
1×104/well. Total RNA was extracted from the following two groups
at either: a) 48 h after transfection, or b) 24 h post RSV infectionwhich
occurred 24 h after siRNA transfection. Polyinosine–polycytidylic acid
(poly I:C) (Takara Co., Shiga, Japan) was selected as a positive control
as an inducer of type I IFN and IFN-inducible genes. The ﬁnal
concentrations of poly I:C were 14 μg, 2.8 μg, 0.56 μg, 0.11 μg and
0.02 μg/100 μl/well. Expression of 2′–5′OAS1mRNAwas quantiﬁed by
real-time PCR with SYBR Green I as described above.
Enzyme-linked immunoassays
Culture supernatants were harvested from culture media in
duplicates. IFN-β concentration was determined using a commercial
sandwich enzyme-linked immunosorbent assay kit (PBL Biomedical
Laboratories, Piscataway, NJ).
Statistics
The results were expressed as mean±standard error (SE). The
paired Student's t-test was used to determine differences between
groups and these were deemed to be signiﬁcant if p b0.05.
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